[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule

Tentative Approvals - December 2004

  ANDA Number Generic Drug Name Applicant Tentative Approval Date
1 76-788 MOMETASONE FUROATE TOPICAL SOLUTION, USP (LOTION) 0.1%   TARO PHARMACEUTICALS USA, INC. 12/3/2004 
2 76-679 MOMETASONE FUROATE CREAM, USP 0.1%   TARO PHARMACEUTICALS USA, INC. 12/3/2004 
3 75-719 SERTRALINE HYDROCHLORIDE TABLETS 25 MG (BASE), 50 MG (BASE), AND 100 MG (BASE)   IVAX PHARMACEUTICALS, INC. 12/9/2004 
4 76-605 GABAPENTIN TABLETS 600 MG AND 800 MG   RANBAXYLABORATORIES LIMITED 12/9/2004 
5 76-610 OXYCODONE HYDROCHLORIDE EXTENDED-RELEASE TABLETS 10 MG, 20 MG, AND 40 MG   TEVA PHARMACEUTICALS USA 12/9/2004 
6 76-864 METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS 750 MG   TEVA PHARMACEUTICALS USA 12/13/2004 
7 76-672 GABAPENTIN ORAL SOLUTION 250 MG/5 ML   TARO PHARMACEUTICAL INDUSTRIES LTD. 12/14/2004 
8 76-327 TOPIRAMATE TABLETS 25 MG, 100 MG, AND 200 MG RANBAXY LABORATORIES LIMITED 12/15/2004 
9 76-747 ROSIGLITAZONE MALEATE TABLETS 2 MG (BASE), 4 MG (BASE), AND 8 MG (BASE)   TEVA PHARMACEUTICALS USA 12/20/2004 
10 76-960 ONDANSETRON HYDROCHLORIDE ORAL SOLUTION 4 MG (BASE)/5 ML   ROXANE LABORATORIES, INC. 12/20/2004 
11 76-719 AMLODIPINE BESYLATE TABLETS 2.5 MG (BASE), 5 MG (BASE), AND 10 MG (BASE)   APOTEX INC. 12/29/2004 

Back to Top     Back to Approvals

Date created: January 6, 2005

horizonal rule